Phase III Data presented at 24 th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) AstraZeneca has announced results from a Phase III comparator trial, which demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results